Prof Michael Dickinson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
117 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Web-Based Cognitive Rehabilitation for Patients With Aggressive Lymphoma With Perceived Cognitive Impairment: A Randomised Pilot Study.
DOI: 10.1002/pon.704692026
Journal article
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma.
DOI: 10.1080/10428194.2026.26311022026
Journal article
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
DOI: 10.1182/blood.20250308722026
Journal article
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
DOI: 10.1182/blood.20250323072026
Journal article
Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era
DOI: 10.1111/bjh.704512019
Journal article
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
DOI: 10.1111/bjh.16069
RECENT SCHOLARLY WORKS
2025
Journal article
DLBCL tumor microenvironment archetype and CD4 T cell conversion to cytotoxic cells are required for response to glofitamab
DOI: 10.1182/blood-2025-5572025
Journal article
Glofitamab Combined with Pola-R-CHP or R-CHOP as First Therapy in Younger Patients with High-Risk Large B-Cell Lymphoma: Results from the COALITION Study
DOI: 10.1200/JCO-25-004812025
Journal article
440 | GOLDILOX: FIRST EXPERIENCE OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS
DOI: 10.1002/hon.70094_4402025
Journal article
197 | CD4 T CELL RECRUITMENT AND DIFFERENTIATION INTO A CYTOTOXIC PHENOTYPE IS ASSOCIATED WITH THE TREATMENT OF PATIENTS WITH GLOFITAMAB TOGETHER WITH R‐CHOP OR POLA‐R‐CHP
DOI: 10.1002/hon.70094_197